Reviva Pharmaceuticals Holdings, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $5.0M | $69.3K |
| FY2021 | — | $28.7M | $29.7M |
| FY2022 | — | $17.6M | $18.5M |
| FY2023 | — | $8.4M | $23.4M |
| FY2024 | — | $812.6K | $13.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $5.0M | $69.3K |
| FY2021 | — | $28.7M | $29.7M |
| FY2022 | — | $17.6M | $18.5M |
| FY2023 | — | $8.4M | $23.4M |
| FY2024 | — | $812.6K | $13.5M |